🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
It is well recognized that older adults can contract pertussis, suffer its ...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00457249
Objectives: * To present the rates of adverse reactions after a dose of DA...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00802867
Treatments Being Tested
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
This study was designed to assess the lot comparability of DAPTACEL, as wel...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00662870
To compare the seroprotection rates and booster responses to Canadian-manuf...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00601835
This single-arm phase II study will assess the impact of tetanus pre-condit...
Status
Terminated
Location
Duke University Medical Center
Start Date
2019-09-30
Trial ID
NCT03927222
The purpose of this study is to evaluate the persistence of immune response...
Status
Completed
Location
Site 02, Center for Vaccinology (CEVAC), Ghent University Hospital
Start Date
2015-04
Trial ID
NCT02382913
Treatments Being Tested
The purpose of this study is to describe the safety and immunogenicity of r...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01439165
Primary objective: * To determine the safety and immunogenicity of tetanus...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT02040636
Pre-licensure studies of GSK Biologicals' Boostrix® have shown it to be gen...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00297856
Treatments Being Tested